Fairtree Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.96M Hold
5,903
1.13% 20
2026
Q1
$2.9M Sell
5,903
-525
-8% -$285K 1.33% 18
2025
Q4
$3.72M Sell
6,428
-1,516
-19% -$857K 1.71% 14
2025
Q3
$3.85M Buy
7,944
+2,409
+44% +$1.12M 2.52% 9
2025
Q2
$2.24M Buy
5,535
+1,724
+45% +$721K 1.69% 15
2025
Q1
$1.9M Buy
3,811
+1,489
+64% +$806K 1.53% 14
2024
Q4
$1.21M Buy
+2,322
New +$1.28M 1.16% 21

Other funds holding TMO

Fairtree Asset Management's TMO Position: Q2 2026 in Review

Fairtree Asset Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 5,903 shares worth $2.96M. The position accounts for 1.13% of the portfolio, ranked #20.

Fairtree Asset Management first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.85M in Q3 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Fairtree Asset Management held 5,903 shares of Thermo Fisher Scientific worth $2.96M as of Q2 2026.
  • Fairtree Asset Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 1.13% of Fairtree Asset Management's portfolio in Q2 2026, its #20 holding.
  • Fairtree Asset Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Fairtree Asset Management's Thermo Fisher Scientific position peaked at $3.85M in Q3 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Fairtree Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.